Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
14.11.2017 22:05:00

Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York.

The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

ABOUT LUMINEX CORPORATION

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Contacts:  

Harriss T. Currie


Sr. Vice President, Finance and CFO


512-219-8020


hcurrie@luminexcorp.com




Matt Scalo


Sr. Director, Investor Relations


512-219-8020


mscalo@luminexcorp.com

 

 

Luminex logo. (PRNewsFoto/LUMINEX CORP.)

 

View original content with multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-to-present-at-the-29th-annual-piper-jaffray-healthcare-conference-300555841.html

SOURCE Luminex Corporation

Nachrichten zu Luminex Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Luminex Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!